Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
Nowadays cytorective surgery and HIPEC is the mainstay of management of advanced stages ovarian cancer. Study was conducted to assess the effectiveness of combined treatment in IIIA-IIIC ovarian cancer, its impact on quality of life. 37 patients of main group (CRS + HIPEC) were compared with 25 pati...
Saved in:
Main Authors: | A. I. Rybin (Author), V. Y. Maksymovskyj (Author), V. V. Pyrogov (Author), R. Ya. Demidchik (Author), A. O. Varabina (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018) -
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019) -
Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series
by: Maya Yasukawa, et al.
Published: (2021) -
Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report
by: Aleksandra Obuchowska, et al.
Published: (2020) -
Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
by: Ioannis A. Voutsadakis
Published: (2017)